Article Versions Notes

Giannopoulou AF, Konstantakou EG, Velentzas AD, Avgeris SN, Avgeris M, Papandreou NC, Zoi I, Filippa V, Katarachia S, Lampidonis AD, et al. Gene-Specific Intron Retention Serves as Molecular Signature that Distinguishes Melanoma from Non-Melanoma Cancer Cells in Greek Patients. International Journal of Molecular Sciences. 2019; 20(4):937. https://doi.org/10.3390/ijms20040937

Giannopoulou, Aikaterini F., Eumorphia G. Konstantakou, Athanassios D. Velentzas, Socratis N. Avgeris, Margaritis Avgeris, Nikos C. Papandreou, Ilianna Zoi, Vicky Filippa, Stamatia Katarachia, Antonis D. Lampidonis, and et al. 2019. "Gene-Specific Intron Retention Serves as Molecular Signature that Distinguishes Melanoma from Non-Melanoma Cancer Cells in Greek Patients" International Journal of Molecular Sciences 20, no. 4: 937. https://doi.org/10.3390/ijms20040937

Giannopoulou, A. F., Konstantakou, E. G., Velentzas, A. D., Avgeris, S. N., Avgeris, M., Papandreou, N. C., Zoi, I., Filippa, V., Katarachia, S., Lampidonis, A. D., Prombona, A., Syntichaki, P., Piperi, C., Basdra, E. K., Iconomidou, V., Papadavid, E., Anastasiadou, E., Papassideri, I. S., Papavassiliou, A. G., ... Stravopodis, D. J. (2019). Gene-Specific Intron Retention Serves as Molecular Signature that Distinguishes Melanoma from Non-Melanoma Cancer Cells in Greek Patients. International Journal of Molecular Sciences, 20(4), 937. https://doi.org/10.3390/ijms20040937